Shared decision making in type 2 diabetes with a support decision tool that takes into account clinical factors, the intensity of treatment and patient preferences: Design of a cluster randomised (OPTIMAL) trial

BMC Family Practice

Volumn 16, Issue 1, 2015, Pages

  Den Ouden, Henk ^a   Vos, Rimke C ^a   Reidsma, Carla ^a   Rutten, Guy Ehm ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Decision support tool; Goal setting; Personalised diabetes treatment; Shared decision making

Indexed keywords

AGED; CLINICAL DECISION SUPPORT SYSTEM; CONTROLLED STUDY; DECISION MAKING; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DECISION MAKING; DECISION SUPPORT SYSTEMS, CLINICAL; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RESEARCH DESIGN; SURVEYS AND QUESTIONNAIRES;

EID: 84925391017     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-015-0230-0     Document Type: Article

References (42)

1. Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbaek A, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet. 2011;378:156-67.
2. Berkowitz SA, Meigs JB, Wexler DJ. Age at type 2 diabetes onset and glycaemic control: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2010. Diabetologia. 2013;56:2593-600.
3. Camara S, Bouenizabila E, Hermans MP, Ahn SA, Rousseau MF. Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes. Diabetes Metab Syndr. 2014;8:145-51.
4. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen ON. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. Engl J Med. 2003;348:383-93.
5. Cleveringa FG, Gorter KJ, van den Donk M, Rutten GE. Combined task delegation, computerized decision support, and feedback improve cardiovascular risk for type 2 diabetic patients: a cluster randomized trial in primary care. Diabetes Care. 2008;31(12):2273-5.
6. Van Hateren KJ, Drion I, Kleefstra N, Groenier KH, Houweling ST, van der Meer K, Bilo HJ. A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19). BMJ Open. 2012;2
7. White RD. Patient empowerment and optimal glycemic control. Curr Med Res Opin. 2012;28:979-89.
8. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Matthews DR, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the study of Diabetes (EASD). Diabetes Care. 2012;35:1364-79.
9. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials. Ann Intern Med. 2011;154:554-9.
10. Robinson JG. ACC/AHA Cholesterol Guideline for Reducing Cardiovascular Risk: What is so Controversial? Curr Atheroscler Rep. 2014;16:413.
11. Esposito K, Maiorino MI, Bellastella G, Giugliano D. New guidelines for metabolic targets in diabetes: clinician's opinion does matter. Endocrine. 2014;46:431-4.
12. Standards of Medical Care in Diabetes 2014. Diabetes Care 2014 vol. 37 no. Supplement 1 S14-S80
13. De Ruijter W, Westendorp RG, Assendelft WJ, Den Elzen WP, De Craen AJ, Le Cessie S, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009;338:3083.
14. Niswender K. Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay. Diabetes Obes Metab. 2010;12:267-87.
15. Nagrebetsky A, Brettell R, Roberts N, Farmer A. Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomised controlled trials. BMJ Open. 2014;4(3):e004107.
16. Mulley AG, Trimble C, Elwyn G. Stop the silent misdiagnosis: patients' preferences matter. BMJ. 2012;345:6572.
17. Stiggelbout AM, Van der Weijden T, De Wit MPT, Frosch D, Légaré F, Montori VM, et al. Shared decision making: really putting patients at the centre of healthcare. BMJ. 2012;344:e256.
18. Joosten EA, Fuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77:219-26.
19. Denig P, Schuling J, Haaijer-Ruskamp F, Voorham J. Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomized controlled trial. BMJ. 2014;349:5651.
20. Barry MJ, Edgman-Levitan S. Shared decision making - the pinnacle of patient-centred care. N Engl J Med. 2012;366:780-1.
21. Coulter A, Collins A. Making shared decision-making a reality: no decision about me, without me. 2011. www.kingsfund.org.uk/publications/nhs-decisionmaking.html
22. International Patient Decision Aids Standards Collaboration. Criteria for judging the quality of patient decision aids. 2005. www.ipdas.ohri.ca/IPDAS-checklist.pdf.
23. Wilkinson MJ, Nathan AG, Huang ES. Personalized Decision Support in Type 2 Diabetes Mellitus: Current Evidence and Future Directions. Curr Diab Rep. 2012;13:205-12.
24. Rodbard D, Vigersky RA. Design of a decision support system to help clinicians manage glycemia in patients with type 2 diabetes mellitus. J Diabetes Sci Technol. 2011;5:402-11.
25. Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T. The statin choice decision aid in primary care: a randomized trial. Patients Educ Couns. 2010;80:138-40.
26. Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Guyatt GH, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009;169:1560-8.
27. Corser W, Holmes-Rovner M, Lein C, Gossain V. A shared decision-making primary care intervention for type 2 diabetes. Diabetes Educ. 2007;33:700-8.
28. Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, et al. Individualized electronic decision support and reminders to improve diabetes care in the community COMPETE II randomized trial. CMAJ. 2009;181:37-44.
29. Janssen PGH, Gorter KJ, Stolk RP, Rutten GEHM. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study. Br J Gen Pract. 2009;59:43-8.
30. Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). In: Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Chur, Switzerland: Harwood Academic Publishers; 1994. p. 111-32.
31. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999;8:79-91.
32. Pouwer F, van der Ploeg HM, Ader HJ, Heine RJ, Snoek FJ. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care. 1999;22:2004-10.
33. Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS. The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabet Med. 2011;28:395-413.
34. The EuroQoL Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
35. Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15:1121-32.
36. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51:1055-68.
37. Ware JEJr&SCD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-83.
38. Welch G. The Diabetes Coping Measure: A measure of cognitive and behavioural coping specific to diabetes. In: Bradley C, editor. Handbook psychology and diabetes: A guide to psychological measurement in diabetes research and practice. Amsterdam: Harwood; 1994. p. 400.
39. Kriston L, Scholl I, Holzel L, Simon D, Loh A, Harter M. The 9-item Shared Decision Making Questionnaire (SDM-Q-9) Development and psychometric properties in a primary care sample. Patient Educ Couns. 2010;80(1):94-9.
40. Scholl I, Kriston L, Dirmaier J, Buchholz A, Härter M. Development and psychometric properties of the Shared Decision Making Questionnaire-physician version (SDM-Q-Doc). Patient Educ Couns. 2012;88:284-90.
41. Degner LF, Sloan JA, Venkatesh P. The Control Preference Scale. Can J Nurs Res. 1997;29:21-43.
42. Kasper J, Heesen C, Köpke S, Fulcher G, Geiger F. Patients' and observers' perceptions of involvement differ. Validation study on inter-relating measures for shared decision making. PLoS One. 2011;6:e26255.